Drug Product
Analytical & Bioanalytical Services
Company Overview
About
Vioser SA is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Biologics Manufacturing, Monoclonal Antibodies, Vaccines
Therapeutic Areas
Respiratory
Allergy
Quick Facts
HQ:Greece
Founded:2015
Employees:155
Capabilities & Services
Core Capabilities
- Biologics Drug Substance
- Biologics Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Sterile Injectable
Production Scales
Commercial Scale
Large Scale (Metric Ton+)
Markets Served
North America
Europe
Regulatory Approvals
Drug Approval SDRMRN
EMA · #APR-WFCY1CZX · 2021-01-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-I8593H05
Issued: 2020-06-11
Expires: 2025-02-20
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-COVDJP1A
Issued: 2020-05-05
Expires: 2025-04-03
WHO GMP
World Health Organization
Cert #: CERT-KYDAIZQE
Issued: 2020-02-06
Expires: 2025-08-02
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-36EP8T14
Issued: 2020-09-05
Expires: 2025-08-18
Loading CDMO intelligence...
Key facts about Vioser SA
- Vioser SA is headquartered in Greece.
- Vioser SA was founded in 2015.
- Vioser SA has 155 employees.
- Vioser SA's capabilities include Biologics Drug Substance, Biologics Manufacturing and Formulation Development.
Find CDMOs like Vioser SA
Directory pages this company appears in, each with the full list of matching manufacturers.